ArticleJournal of pharmaceutical health care and sciences2021

Cost-effectiveness of preemptive skin treatment to prevent skin-toxicity caused by panitumumab in third-line therapy for KRAS wild type metastatic colorectal cancer in Japan.

Munenobu Kashiwa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.